Literature DB >> 23321913

Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Chihiro Mayama1, Makoto Araie.   

Abstract

An association between glaucoma development or progression and compromised ocular blood flow has been postulated as a result of population-based studies and prospective cohort studies. Blood flow in the optic nerve head (ONH) is of primary importance in the pathogenesis of glaucoma. The potential to modify the blood flow in the ONH and its related structures has been reported in various agents, including topical antiglaucoma drugs and systemic drugs such as calcium channel antagonists, which are reviewed in this manuscript. Clinical implications of the improvement in ocular blood flow on the treatment of glaucomatous optic neuropathy require further investigation.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23321913     DOI： 10.1007/s10384-012-0220-x

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


  248 in total

1.  Short-term effects of topical levobunolol on the human retinal circulation.

Authors:  M Leung; J E Grunwald
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

2.  Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension.

Authors:  G Fuchsjäger-Mayrl; B Wally; G Rainer; W Buehl; T Aggermann; J Kolodjaschna; G Weigert; E Polska; H-G Eichler; C Vass; L Schmetterer
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients.

Authors:  A Harris; O Arend; H S Chung; L Kagemann; L Cantor; B Martin
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

4.  Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits.

Authors:  Takahiro Akaishi; Hiroaki Kurashima; Noriko Odani-Kawabata; Naruhiro Ishida; Masatsugu Nakamura
Journal:  J Ocul Pharmacol Ther       Date:  2010-04       Impact factor: 2.671

5.  Retinal peripapillary blood flow before and after topical brinzolamide.

Authors:  Michele Iester; Michele Altieri; Georg Michelson; Paolo Vittone; Carlo E Traverso; Giovanni Calabria
Journal:  Ophthalmologica       Date:  2004 Nov-Dec       Impact factor: 3.250

6.  The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol.

Authors:  Umit Ubeyt Inan; Sitki Samet Ermis; Ayse Orman; Ersel Onrat; Aylin Yucel; Faruk Ozturk; Ali Asagidag; Atac Celik
Journal:  J Ocul Pharmacol Ther       Date:  2004-08       Impact factor: 2.671

7.  Effects of topical phenylephrine on blood flow in the posterior segments of monkey and aged human eyes.

Authors:  Jun Takayama; Asuka Mishima; Kiyoshi Ishii
Journal:  Jpn J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.447

8.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

9.  Diurnal variation in pulsatile ocular blood flow in normal and glaucomatous eyes.

Authors:  K G Claridge; S E Smith
Journal:  Surv Ophthalmol       Date:  1994-05       Impact factor: 6.048

10.  Local effect of topical FP-receptor agonists on retinal vessels of the ipsilateral posterior retina in normal rabbit eyes.

Authors:  Masaaki Ohashi; Chihiro Mayama; Kiyoshi Ishi; Makoto Araie
Journal:  Clin Exp Ophthalmol       Date:  2008-11       Impact factor: 4.207
View more
  8 in total

1.  Posture-induced changes in intraocular pressure: comparison of pseudoexfoliation glaucoma and primary open-angle glaucoma.

Authors:  Ahmet Ozkok; Nevbahar Tamcelik; Olgu Capar; Eray Atalay
Journal:  Jpn J Ophthalmol       Date:  2014-03-15       Impact factor: 2.447

Review 2.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

3.  Ocular blood flow and choroidal thickness in ocular hypertension.

Authors:  Serdar Bayraktar; Ali İpek; Tamer Takmaz; Yelda Yildiz Tasci; Mehmet Can Gezer
Journal:  Int Ophthalmol       Date:  2021-11-25       Impact factor: 2.031

4.  Central macular OCTA parameters in glaucoma.

Authors:  Takashi Nishida; Won Hyuk Oh; Sasan Moghimi; Adeleh Yarmohammadi; Huiyuan Hou; Ryan Caezar C David; Alireza Kamalipour; Takuhei Shoji; Nevin El-Nimri; Jasmin Rezapour; Linda M Zangwill; Robert N Weinreb
Journal:  Br J Ophthalmol       Date:  2021-08-23       Impact factor: 5.908

Review 5.  Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

Authors:  Ari Stoner; Alon Harris; Francesco Oddone; Aditya Belamkar; Alice Chandra Verticchio Vercellin; Joshua Shin; Ingrida Januleviciene; Brent Siesky
Journal:  Br J Ophthalmol       Date:  2021-08-25       Impact factor: 5.908

6.  Optical coherence tomography angiography of optic disc perfusion in glaucoma.

Authors:  Yali Jia; Eric Wei; Xiaogang Wang; Xinbo Zhang; John C Morrison; Mansi Parikh; Lori H Lombardi; Devin M Gattey; Rebecca L Armour; Beth Edmunds; Martin F Kraus; James G Fujimoto; David Huang
Journal:  Ophthalmology       Date:  2014-03-12       Impact factor: 12.079

7.  First insight into the proteome landscape of the porcine short posterior ciliary arteries: Key signalling pathways maintaining physiologic functions.

Authors:  Caroline Manicam; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus; Adrian Gericke
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

8.  Retinal vessel density from optical coherence tomography angiography to differentiate early glaucoma, pre-perimetric glaucoma and normal eyes.

Authors:  Handan Akil; Alex S Huang; Brian A Francis; Sirinivas R Sadda; Vikas Chopra
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.